Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $3.3 million.

  • Ultralife's Change in Accured Expenses fell 3649.83% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $451000.0, marking a year-over-year decrease of 7938.76%. This contributed to the annual value of $215000.0 for FY2024, which is 10724.39% up from last year.
  • As of Q3 2025, Ultralife's Change in Accured Expenses stood at $3.3 million, which was down 3649.83% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Change in Accured Expenses ranged from a high of $5.3 million in Q3 2024 and a low of -$2.9 million during Q3 2023
  • For the 4-year period, Ultralife's Change in Accured Expenses averaged around -$165333.3, with its median value being -$570500.0 (2023).
  • In the last 5 years, Ultralife's Change in Accured Expenses crashed by 133375.8% in 2024 and then soared by 38454.11% in 2025.
  • Quarter analysis of 4 years shows Ultralife's Change in Accured Expenses stood at -$2.2 million in 2021, then surged by 76.09% to -$520000.0 in 2023, then crashed by 379.42% to -$2.5 million in 2024, then soared by 234.14% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, -$2.2 million for Q2 2025, and $1.8 million during Q1 2025.